Exclusive Life Science Feature
no shortage of Alzheimer's patients." Garnett
ronment?" Garnett thinks the industry needs
believes if patient engagement works well for
to challenge itself to improve the patient
healthcare providers like hospitals, why not
and investigator experience. One solution
take the same approach when trying to recruit
involved the collaboration between Lilly, J&J;,
for clinical trials. "We are looking at running a
and Merck to share trial investigator good
Muscular Dystrophy trial. As a result, we are in
clinical practice (GCP) training information.
very close contact with MD support groups,"
Prior to this, if investigators worked for one
he shares. "We know that when we are ready
of these companies, they had to do three
to start, we will have every patient ready to
separate, and essentially the same, training
be screened and entered." Getting better at
sessions. The collaborative effort to share the
recruiting is a critical component to successful
GCP info was well received by the industry. It
clinical trial execution. So too is getting folks
eliminated redundant training, saving money
to want to participate more than once.
for everyone, and the investigators' most
"The biggest determining factor of how long it is going to take to run
One of the realities in the clinical trial space a Phase 3 study is the amount of time it takes to recruit patients,"
valuable resource — time. TransCelerate
is the majority of patients and investigators says Timothy Garnett, chief medical officer, Eli Lilly
BioPharma, which now numbers nearly 20
who participate in a study do so only once.
member companies, built upon this in devel"What factors make this an experience participants often don't
oping its site qualification and training resources.
want to repeat?" asks Garnett. "How can we become more patient
There are a number of ways to improve the clinical trial experiand investigator friendly in an ever increasingly competitive envience for patients. For example, participating in a placebo-con-
DATATRAK ONE® Delivering the
Complete unified eClinical Experience
EŽKŶĞůƐĞKīĞƌƐĂdƌƵůLJ
uŶŝĮĞĚ^ŽůƵƟŽŶ
EŽKŶĞ
Phase I
Phase II
ͻ Phase III
ͻ Phase IV
Quicker Training &ĂƐƚĞƌsĂůŝĚĂƟŽŶͻ Easier Change Orders
ĞƩĞƌĂƚĂͻWĞƌŝŽĚ
datatrak.com
+1.440.443.0082 ŵĂƌŬĞƟŶŐΛĚĂƚĂƚƌĂŬ͘ĐŽŵ
February 2014
LifeScienceLeader.com
29